- Gallup: Take Care Clinics top in customer service
- The Little Clinic adds new insurance provider to accepted plans
- With health reform outlook dimmed, pharmacy can’t abandon its agenda
- Bartell to cease filling Medicaid prescriptions at 15 locations
- More progress needed in health information technology
FORT WASHINGTON, Pa. McNeil Consumer Healthcare on Thursday issued yet another recall of 21 lots of over-the-counter medicines. This action is a follow-up to a product recall that McNeil originally announced on Jan. 15, which was initiated following consumer complaints of a musty or moldy odor, which has been linked to the presence of trace amounts of a chemical called 2,4,6-tribromoanisole.
Between Jan. 15 and July 8, McNeil has made seven recall announcements, not all because of the TBA chemical, however. The latest lots are being added to the list of recalled products as a precautionary measure after a continuing internal review determined that some packaging materials used in the lots had been shipped and stored on the same type of wooden pallet that was tied to the presence of TBA in earlier recalled lots. All lots involved in the recall were produced before the Jan. 15 recall, after which McNeil stopped accepting shipments of materials from its suppliers on that type of pallet.
McNeil has created a website, McNeilProductRecall.com/index.jhtml, that outlines all products affected from each of the recalls.